Gabriella D'ORAZI

Associate Professor

Saint Camillus International University of Health Sciences

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gabriella D'ORAZI is an Associate Professor at Saint Camillus International University of Health and Medical Sciences in Italy. Her research primarily focuses on cancer biology, specifically the roles of mutant p53, post-translational modifications, and epigenetic changes in various cancer types. Recent publications include investigations into therapeutic interventions and biomarkers related to pancreatic and colon cancers, as well as studies on the mechanisms of drug resistance in lymphoma.

Articles (10)

Year:

2025

Cancer is one of the major causes of death globally, accounting for 10 million deaths in 2020 [...]

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (5)

Michele Di Crosta

Sapienza University of Rome

ITALY

View details

Marco Tafani

Associate Professor

Università degli Studi di Roma La Sapienza Facoltà di Medicina e Odontoiatria

ITALY

View details

Roberta Santarelli

Associate Professor

Università degli Studi di Roma La Sapienza Dipartimento di Scienze Statistiche

ITALY

View details

Mara Cirone

ITALY

View details

Alessandra Verdina

IRCCS Regina Elena National Cancer Institute

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gabriella D'ORAZI

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Valemetostat–SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells

Cancer Chemotherapy: Combination with Inhibitors (Volume I)

Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53

SAHA/5-AZA Enhances Acetylation and Degradation of mutp53, Upregulates p21 and Downregulates c-Myc and BRCA-1 in Pancreatic Cancer Cells

Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions

HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies

ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression

NRF2 activation in BON-1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)-curcumin compound: A pilot study

New insights into the Bortezomib-induced cytotoxic and resistance mechanisms in a primary effusion lymphoma mouse model

HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets

Collaborators (5)

Michele Di Crosta

Marco Tafani

Roberta Santarelli

Mara Cirone

Alessandra Verdina

Make your next move.